Skip to content

SankoreAfrican research intelligence

Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Eric M. Kanza · Sankore

Eric M. Kanza

Name matching only

This profile was assembled from author names on publications. Open indexes routinely split one researcher across several such profiles, so these totals may be incomplete.

Publications

4

Citations

53

h-index

3

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

2

Affiliations

Every institution this scholar has appeared with on a work, by how many.

University of Health and Allied Sciences1 works
Université Catholique du Graben1 works
Programme National Multisectoriel de Lutte contre le sida1 works

Publications

4 works in the graph, newest first.

Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia
2024Parasites & VectorsJournalOpen accessFirst author5 citations10.1186/s13071-023-06087-3
Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?
2023Philosophical Transactions of the Royal Society B Biological SciencesJournalOpen access35 citations10.1098/rstb.2022.0277
A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis
2023PLoS neglected tropical diseasesJournalOpen access11 citations10.1371/journal.pntd.0011365
New Research Aims to Optimize Therapy Against Onchocerciasis.
2022PubMedJournalOpen access

2 citations